Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30744930 | 0.82 | OPRM1 (0.40) | LMNAOPRM1 | |
| SCHEMBL12199856 | 0.80 | LMNA (0.43) | LMNAOPRM1 | |
| SCHEMBL17123854 | 0.78 | PRKD3 (0.36) | LMNA | |
| SCHEMBL28987877 | 0.77 | LMNA (0.36) | LMNAOPRM1 | |
| SCHEMBL28387932 | 0.77 | ALDH1A1 (0.36) | LMNA | |
| Hydrochloric Acid SCHEMBL31373200 | 0.76 | DNM1 (0.40) | LMNA | |
| Hydrochloric Acid SCHEMBL10448112 | 0.76 | DNM1 (0.40) | LMNA | |
| Hydrochloric Acid SCHEMBL31373199 | 0.76 | DNM1 (0.40) | LMNA | |
| SCHEMBL7059549 | 0.76 | USP2 (0.33) | — | |
| SCHEMBL544597 | 0.76 | OPRM1 (0.33) | LMNAOPRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11066539-B2 | Rubber composition | KAO CORPORATION (JP) | 2021-07-20 | — | — | US | disclosed |
| US-10717852-B2 | Additive for resins | KAO CORPORATION (JP) | 2020-07-21 | — | — | US | disclosed |
| US-20200048438-A1 | RUBBER COMPOSITION | KAO CORPORATION (JP) | 2020-02-13 | — | — | US | disclosed |
| EP-3299412-B1 | ADDITIVE FOR RESINS | KAO CORP (JP) | 2019-07-31 | — | — | EP | disclosed |
| US-20180142088-A1 | ADDITIVE FOR RESINS | KAO CORPORATION (JP) | 2018-05-24 | — | — | US | disclosed |
| EP-3299412-A1 | ADDITIVE FOR RESINS | Kao Corporation (JP) | 2018-03-28 | — | — | EP | disclosed |
| EP-2226354-B1 | Rubber composition | BRIDGESTONE CORP (JP) | 2012-12-12 | — | — | EP | disclosed |
| US-8110625-B2 | Rubber composition | BRIDGESTONE CORPORATION (JP) | 2012-02-07 | — | — | US | disclosed |
| EP-2223958-B1 | Rubber composition | BRIDGESTONE CORP (JP) | 2011-12-28 | — | — | EP | disclosed |
| US-20100298488-A1 | RUBBER COMPOSITION | BRIDGESTONE CORPORATION (JP) | 2010-11-25 | — | — | US | disclosed |
| US-7799856-B2 | Rubber composition | BRIDGESTONE CORPORATION (JP) | 2010-09-21 | — | — | US | disclosed |
| EP-2226354-A1 | Rubber composition | Bridgestone Corporation (JP) | 2010-09-08 | — | — | EP | disclosed |
| EP-2223958-A1 | Rubber composition | Bridgestone Corporation (JP) | 2010-09-01 | — | — | EP | disclosed |
| US-20040249032-A1 | Rubber composition | BRIDGESTONE CORPORATION (JP) | 2004-12-09 | — | — | US | disclosed |
| EP-1435375-A1 | RUBBER COMPOSITION | Bridgestone Corporation (JP) | 2004-07-07 | — | — | EP | disclosed |
| EP-1081187-B1 | Rubber composition containing silica or silicate and salt of an amine | BRIDGESTONE CORP (JP) | 2004-02-18 | — | — | EP | disclosed |
| US-6355710-B1 | MIXTURE WITH FILLER AND AMINE SALT | BRIDGESTONE CORPORATION (JP) | 2002-03-12 | — | — | US | disclosed |
| EP-1081187-A2 | Rubber composition containing silica or silicate and salt of an amine | BRIDGESTONE CORPORATION (JP) | 2001-03-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100298488-A1 | RUBBER COMPOSITION | RAD50, RAD54L, VCL | LMNA 377/4885OPRM1 1596/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.